A Canadian pharmaceutical company is warning consumers not to use some of its eye drops because of potential microbial growth that may result in eye infections. Montreal-based Pendopharm, a division of Pharmascience Inc., is recalling the 5 mL and 10 mL packs of its Cromolyn Eye Drops , with the Drug Identification Number 02009277.
The products have the following expiry dates: April 30, 2025; April 30, 2026; Nov. 30, 2026; Jan. 31, 2026; and Aug.
31, 2026. "Children, pregnant people, seniors and people with weaker immune systems may be more susceptible to infection or 'complications from microbial contamination,'" according to a public advisory Wednesday on the Canadian government's website. On the other hand, for healthy individuals, the risk of developing serious eye infections from potentially contaminated eye drops is "relatively low" and the infection may even heal on its own, read the advisory.
The specialty pharmaceutical company advises consumers to return the product to a pharmacy, which will properly dispose it. "Consult a health care professional if you have used this product and have health concerns," the advisory added. Those who want to contact the company can reach Pendopharm by calling 1-888-550-6060 or emailing medinfo@pendopharm.
com. As well, individuals can report any side-effects or complaints to Health Canada. Product testing The product is an over-the-counter drug meant to prevent and alleviate symptoms of seasonal allergic conjunctivitis, a common type .
